Sibylle Loibl
0000-0001-6488-4958
Publication & Citation Trends
Publications
0 total
Abstract ED4-4: Lobular/pleomorphic Breast Cancer
Cited by 0
Semantic Scholar
Pitfalls in machine learning‐based assessment of tumor‐infiltrating lymphocytes in breast cancer: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer OA
Cited by 43
Semantic Scholar
Abstract PD4-02: PD4-02 Spatial and temporal heterogeneity of predictive and prognostic signatures in triple-negative breast cancer treated with neoadjuvant combination immune-chemotherapy
Cited by 0
Semantic Scholar
SA 9.2 Optimal systemic therapy for residual disease in TNBC OA
Cited by 0
Semantic Scholar
Sacituzumab govitecan in HR+ and HER2- metastatic breast cancer: for all or for some?
Cited by 2
Semantic Scholar
Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer OA
Cited by 24
Semantic Scholar
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer OA
Cited by 45
Semantic Scholar
The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus OA
Cited by 17
Semantic Scholar
Research Topics
Breast Cancer Treatment Studies
(623)
HER2/EGFR in Cancer Research
(427)
Cancer Treatment and Pharmacology
(357)
Advanced Breast Cancer Therapies
(340)
Cancer Genomics and Diagnostics
(192)
Affiliations
Université Paris-Sud
Northwestern University
Ontario Institute for Cancer Research
Goethe University Frankfurt
Roche (Switzerland)